Haarzellleukämie = ResterkrankungHairy cell leukemia

Hairy cell leukemia was initially described as a distinct entity in 1958. It is rare B-cell malignancy characterized by an indolent course. Advances in the treatment and understanding of the biology of hairy cell leukemia have made the disease exquisitely amenable to treatment. This review summarize...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Dietrich, Sascha (VerfasserIn) , Andrulis, Mindaugas (VerfasserIn) , Zenz, Thorsten (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Deutsch
Englisch
Veröffentlicht: 20. März 2015
In: Der Internist
Year: 2015, Jahrgang: 56, Heft: 4, Pages: 381-390
ISSN:1432-1289
DOI:10.1007/s00108-014-3599-2
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1007/s00108-014-3599-2
Verlag, Volltext: https://link.springer.com/article/10.1007/s00108-014-3599-2
Volltext
Verfasserangaben:S. Dietrich, M. Andrulis, T. Zenz
Beschreibung
Zusammenfassung:Hairy cell leukemia was initially described as a distinct entity in 1958. It is rare B-cell malignancy characterized by an indolent course. Advances in the treatment and understanding of the biology of hairy cell leukemia have made the disease exquisitely amenable to treatment. This review summarizes the present understanding of hairy cell leukemia with a particular focus on the development of novel and targeted approaches to treatment.
Beschreibung:Gesehen am 21.07.2017
Beschreibung:Online Resource
ISSN:1432-1289
DOI:10.1007/s00108-014-3599-2